Latest news with #PetVivo
Miami Herald
14 hours ago
- Business
- Miami Herald
New to The Street's Documentary Specials Break Records: IMG Academy Surpasses 126,000 Views in Just 12 Days
PetVivo and Acurx Pharmaceuticals Exceed 200,000 Views as investor Demand for Long-Form Corporate Storytelling Surges NEW YORK CITY, NEW YORK / ACCESS Newswire / June 9, 2025 / New to The Street, the nation's leading financial media brand for long-form investor communications, proudly announces record-breaking viewership across its newest documentary-style programs. Its latest feature on IMG Academy surpassed 126,000 views in only 12 days on YouTube, marking a new milestone for the brand's flagship long-form format. Meanwhile, features on PetVivo Holdings, Inc. (NASDAQ:PETV) and Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) have crossed 200,000 views, reinforcing New to The Street's position as a go-to media platform for delivering cinematic, investor-focused storytelling at scale. Watch the full specials here: IMG Academy: PetVivo: Acurx Pharmaceuticals: Since 2009, New to The Street has produced thousands of 7-10-minute segments featuring public company CEOs and C-suite leaders, broadcast as sponsored programming on Bloomberg Television and FOX Business. The addition of 27-28-minute documentary specials represents a strategic evolution in media format-now delivering immersive brand narratives that are licensed, broadcast, and featured across a YouTube network with more than 2.5 million subscribers. Following national TV exposure, these pieces are supported by earned media syndication, social media campaigns, and Times Square billboard placements-providing a 360° distribution model for maximum investor engagement. For media, sponsorship, or booking inquiries, contact:Monica BrennanMonica@ About New to The Street:New to The Street is a nationally syndicated financial media platform delivering long-form television interviews, corporate documentaries, and multi-channel distribution across Bloomberg TV, FOX Business, as sponsored programming and one of the largest business YouTube channels in the industry. With over 245 million weekly household reach and 2.54M+ subscribers, the brand is redefining how business stories are told-and seen. SOURCE: New To The Street
Associated Press
a day ago
- Business
- Associated Press
New to The Street's Documentary Specials Break Records: IMG Academy Surpasses 126,000 Views in Just 12 Days
PetVivo and Acurx Pharmaceuticals Exceed 200,000 Views as investor Demand for Long-Form Corporate Storytelling Surges NEW YORK CITY, NEW YORK / ACCESS Newswire / June 9, 2025 / New to The Street, the nation's leading financial media brand for long-form investor communications, proudly announces record-breaking viewership across its newest documentary-style programs. Its latest feature on IMG Academy surpassed 126,000 views in only 12 days on YouTube, marking a new milestone for the brand's flagship long-form format. Meanwhile, features on PetVivo Holdings, Inc. (NASDAQ:PETV) and Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) have crossed 200,000 views, reinforcing New to The Street's position as a go-to media platform for delivering cinematic, investor-focused storytelling at scale. Watch the full specials here: 'These are not typical interviews-they're broadcast-quality mini-documentaries that resonate across investor and consumer audiences alike,' said Vince Caruso, Co-Founder and CEO of New to The Street. 'We're combining Wall Street-level insight with storytelling that connects emotionally and visually. Companies are seeing it translate directly into visibility and traction.' Since 2009, New to The Street has produced thousands of 7-10-minute segments featuring public company CEOs and C-suite leaders, broadcast as sponsored programming on Bloomberg Television and FOX Business. The addition of 27-28-minute documentary specials represents a strategic evolution in media format-now delivering immersive brand narratives that are licensed, broadcast, and featured across a YouTube network with more than 2.5 million subscribers. Following national TV exposure, these pieces are supported by earned media syndication, social media campaigns, and Times Square billboard placements-providing a 360° distribution model for maximum investor engagement. 'The data is crystal clear-audiences are spending more time with high-quality, long-form content,' added Caruso. 'This format allows companies to fully control their narrative, showcase innovation, and build trust-all while generating viewership numbers that rival traditional media.' For media, sponsorship, or booking inquiries, contact: Monica Brennan [email protected] About New to The Street: New to The Street is a nationally syndicated financial media platform delivering long-form television interviews, corporate documentaries, and multi-channel distribution across Bloomberg TV, FOX Business, as sponsored programming and one of the largest business YouTube channels in the industry. With over 245 million weekly household reach and 2.54M+ subscribers, the brand is redefining how business stories are told-and seen. SOURCE: New To The Street press release
Yahoo
4 days ago
- Business
- Yahoo
PetVivo and Commonwealth Partner to Advance Equine Wellness Across Thoroughbred Racing
Minneapolis, MN, June 06, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), an emerging biomedical device company focused on animal health, today announced a strategic collaboration with Commonwealth, the syndicated ownership group behind 2023 Kentucky Derby winner Mage, and 2022 Dubai World Cup Champion Country Grammer. The partnership centers on the clinical use and promotion of SPRYNG® with OsteoCushion® Technology, PetVivo's cutting-edge intra-articular device designed to support joint health and durability, and Precise PRP™, a first-in-class off-the-shelf platelet-rich plasma (PRP) product designed for use by veterinarians in elite equine athletes. As part of this collaboration, Commonwealth intends to integrate SPRYNG and PrecisePRP, when possible, into the care protocols of its top-tier thoroughbred stable, using the technology as both a preventative measure and a treatment solution to promote joint health, extend performance longevity, and support recovery in high-impact training and racing environments. In addition to clinical implementation, PetVivo and Commonwealth will explore co-branded content, educational initiatives, and industry outreach designed to elevate awareness around joint wellness and support broader adoption of SPRYNG and PrecisePRP across the equine health community. John Lai, CEO of PetVivo, commented, "Partnering with Commonwealth, a proven leader in the highest levels of the sport, marks a major milestone for SPRYNG and PrecisePRP. Their championship-caliber horses and progressive approach to wellness makes them the ideal partner to showcase the benefits of our technology. Together, we're advancing a shared vision of equine health that emphasizes performance, longevity, and science-backed care." Chase Chamberlin, CEO of Commonwealth, stated, 'At Commonwealth, our mission is to champion our equine athletes on and off the track. With HISA's new welfare protocols raising the bar for horse safety, SPRYNG and PrecisePRP are game‑changing advances in preventive and rehabilitative joint care. This partnership allows us to push the boundaries of equine medicine, while minimizing injury risk and downtime, so our horses can perform at their best. We're proud to join forces with PetVivo to deliver cutting‑edge treatments that safeguard the health and future of our champions.' Mike Eldred, Board Director at PetVivo, commented, 'We are excited to join forces with Commonwealth in advancing the clinical use of SPRYNG and Precise PRP. This partnership represents a significant step forward in our commitment to being the market leader in equine joint health and regenerative medicine. By combining PetVivo's clinical expertise and commercial capabilities, with Commonwealth's equine industry knowledge and network, we aim to provide veterinarians with cutting-edge, effective solutions that enhance recovery and long-term soundness in competitive horses.' About Commonwealth Commonwealth is a leading investment platform that allows fans to buy equity shares in thoroughbred racehorses starting at $50 per share. Dedicated to providing thrilling fan experiences that create lifelong memories and bring them closer than ever to the sport, Commonwealth campaigned 2023 Kentucky Derby winner Mage and the world's highest earning racehorse of 2022, Country Grammer. Learn more and download the app here. About PetVivo Holdings, Inc. PetVivo Holdings Inc. (OTCQB: PETV; OTCPINK: PETVW) is a biomedical device company focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. PetVivo has a portfolio of twelve patents and six proprietary trade secrets that protect the company's biomaterials, products, production processes and methods of use. The company's lead products SPRYNG, is a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses. The company recently launched PrecisePRP, a first-in-class, off-the-shelf, allogenic, platelet-rich plasma (PRP) product. For more information about PetVivo Holdings, Inc. and our revolutionary products, Spryng and PrecisePRP, please contact info1@ or visit or Contact Information:John Lai, CEOPetVivo Holdings, info1@ 405-6216 Forward-Looking Statements: The foregoing material may contain 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company's proposed development and commercial timelines, and can be identified by the use of words such as 'may,' 'will,' 'expect,' 'project,' 'estimate,' 'anticipate,' 'plan,' 'believe,' 'potential,' 'should,' 'continue' or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to PetVivo and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the PetVivo's business are described in detail in PetVivo's Annual Report on Form 10-K for the year ended March 31, 2024, and other periodic and current reports filed with the Securities and Exchange Commission. PetVivo is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Yahoo
22-05-2025
- Business
- Yahoo
Petvivo Holdings, Inc. and PiezoBioMembrane Inc. Announce Master Services Agreement to Jointly Develop Innovative Functional Biomaterials
MINNEAPOLIS, May 22, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively referred to herein as the "Company" or 'PetVivo') an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for animals, and PiezoBioMembrane, Inc ('PiezoBio')., a pioneer in biodegradable piezoelectric materials intended for implantable applications, today announced a transformative Master Services Agreement. The strategic partnership centers on collaborative research and development of revolutionary functional biomaterials that include piezoelectric nanofibers incorporated into a biocompatible biomaterial comprised of natural materials that mimics mammalian extracellular matrix ('ECM'). We believe these functional biomaterials can be biologically activated by piezoelectric stimulation to promote regeneration and/or remodeling of damaged or injured tissue and bone in animals and humans. Partnership Structure and Strategic Benefits Under the Master Services Agreement, PetVivo and PiezoBio will collaboratively work to combine PetVivo's ECM biomaterial with PiezoBio's piezoelectric nanofibers. The anticipated piezo-biomaterial derived from this collaboration is intended to have functional attributes that can be biologically activated, thereby promoting enhanced healing, regeneration and/or remodeling of damaged or injured mammalian tissue and bone. PetVivo has developed and is commercializing a biocompatible biomaterial that mimics mammalian tissue. The Company has recognized the many advantages of matching the composition of implantable biomaterials to the native tissue surrounding the implant site and the importance of creating biomatrix materials that exhibit limited to no adverse effects when placed in the body of an animal or human. PetVivo has successfully created a biomaterial that is included in several new product lines that possess these assimilating and biocompatible properties. One example of PetVivo's biocompatible, ECM-like products is SPRYNG® with OsteoCushion® Technology. Spryng is an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles. The microparticles of Spryng have been found to adsorb onto the joint synovial lining of animals and subsequently integrate with the animal's subsynovial tissue. Such action promotes the restoration of proper joint mechanics, thereby aiding in the management of noninfectious sources of joint pain such as joint instability, degenerative joint disease and osteoarthritis. Mike Eldred, Board Member of PetVivo Holdings, Inc. said, "PetVivo has been developing the next-generation of biomaterials that mimic mammalian tissue using all-natural components, which are commonly found in the extracellular matrix of animals and humans. We aim to leverage our in-house biomaterial expertise, along with the exceptional piezoelectric material expertise of PiezoBio, to develop the next generation of functional biomaterials. This collaboration with PiezoBio will enable us to advance our research and potentially result in innovative medical devices and therapeutics that can be transformative for veterinarians and their patients." PiezoBio has developed a biodegradable piezoelectric nanomaterial that can act as a battery-less electrical stimulator to promote enhanced cell activity when implanted in mammalian tissue or bone. The technology provides, for the first time, (1) a wireless, battery-free and self-stimulated technology to generate electrical stimulation for inducing tissue/bone regeneration, (2) a tool to systematically study interaction between cells and surface charge for tissue/bone regeneration, and (3) an approach to design and create a novel nanomaterial-based biodegradable piezoelectric scaffold which can form highly-regenerative replacement for treatment of damaged or injured tissue and bone. "We expect that this collaboration will generate synergy by combining PetVivo's experience in developing biocompatible biomaterials made from natural materials and our expertise in piezoelectric materials that promote therapeutic healing and regeneration," said Linh Le, Chief Executive Officer at PiezoBioMembrane, Inc. "Through open innovation, we aim to actively expand our development efforts beyond our core areas related to piezoelectric materials to enhanced functional biomaterials that may be used in a multitude of therapeutic fields." For more information about PetVivo Holdings, Inc. and our revolutionary products, Spryng with OsteoCushion Technology and PrecisePRP, please contact info1@ or visit or For more information about PiezoBioMembrane, Inc. and our revolutionary piezoelectric material platform, please contact hello@ or visit About PetVivo Holdings, Inc. PetVivo Holdings Inc. (OTCQB: PETV; OTCPINK: PETVW) is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics. PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of twenty-one patents protects the Company's biomaterials, products, production processes and methods of use. The Company's lead products SPRYNG™ with OsteoCushion™ technology, a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses, and PrecisePRP, a first-in-class, off-the-shelf, platelet-rich plasma (PRP) product designed for use by veterinarians, are currently available for commercial sale. CONTACT: John Lai, CEO PetVivo Holdings, Inc. Email: info1@ (952) 405-6216 About PiezoBioMembrane, Inc. PiezoBio is engaged in the research, development, and manufacturing of piezoelectric biomaterials for healthcare applications. The company is committed to harnessing innovative science and technology to deliver impactful solutions that advance both human and animal health. As a spin-off from the University of Connecticut, PiezoBio pursues strategic partnerships to accelerate product development and reduce time-to-market. CONTACT: Linh Le, CEO PiezoBioMembrane, Inc. Email: hello@ Forward-Looking Statements: The foregoing material may contain 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company's proposed development and commercial timelines, and can be identified by the use of words such as 'may,' 'will,' 'expect,' 'project,' 'estimate,' 'anticipate,' 'plan,' 'believe,' 'potential,' 'should,' 'continue' or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the Company's business are described in detail in the Company's Annual Report on Form 10-K for the year ended March 31, 2024 and other periodic and current reports filed with the Securities and Exchange Commission. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Miami Herald
12-05-2025
- Business
- Miami Herald
New to The Street Airs Episode #655 Tonight on Bloomberg at 6:30 PM EST Featuring Synergy CHC (Focus Factor(R), Flat Tummy Tea, Keto + ACV), Health In Tech, Skip Barber Racing School, LightPath Technologies, and Roadzen
Sponsored by The Sustainable Green Team's Waterless Garden Initiative and PetVivo's SPRYNG NEW YORK CITY, NEW YORK / ACCESS Newswire / May 10, 2025 / New to The Street, one of the nation's longest-running and most trusted business television brands, will air Episode #655 tonight, Saturday, May 10, 2025, at 6:30 PM EST on Bloomberg Television as sponsored programming. This episode features five forward-thinking companies making an impact in their sectors: Synergy CHC Corp. (NASDAQ:SNYR) - A health and wellness leader spotlighting its flagship Focus Factor®, the brain supplement known for boosting focus, concentration, and energy. Also featured: viral wellness hits Flat Tummy Tea® and Flat Tummy Keto + Apple Cider Vinegar (ACV) - empowering health-conscious consumers In Tech (NASDAQ:HIT) - A rapidly growing insurtech innovator creating smart health plan solutions for brokers, employers, and Barber Racing School - The legendary racing school shaping the next generation of drivers and expanding into events, eSports, and branded motorsport Technologies, Inc. (NASDAQ:LPTH) - A global photonics leader delivering precision infrared and optical technologies for the defense, aerospace, and telecom Inc. (NASDAQ:RDZN) - An AI-driven auto insurance and mobility tech company revolutionizing roadside support, real-time claims, and connected vehicle services. Episode 655 is presented with sponsorship from: The Sustainable Green Team (OTCQX:SGTM) - Showcasing their Waterless Garden Initiative, delivering innovative, drought-proof landscaping Holdings, Inc. (NASDAQ:PETV) - Developers of SPRYNG, a cutting-edge veterinary device helping improve joint function in animals through natural biomaterial science. "This episode is a showcase of innovation across wellness, insurance, racing, optics, and AI," said Vince Caruso, Founder and CEO of New to The Street. "We're proud to present brands like Focus Factor® and Flat Tummy, alongside disruptive technology companies reshaping their industries." The episode is hosted by Jane King, financial journalist and anchor known for her insightful interviews and market coverage. Broadcast Details:Show Title:New to The StreetEpisode #: 655Air Date: Saturday, May 10, 2025Time: 6:30 PM ESTNetwork: Bloomberg Television (as sponsored programming)Streaming: - The fastest-growing financial channel with over 2.47 million subscribers For media inquiries, please contact:Monica BrennanDirector of CommunicationsMonica@ About New to The StreetNew to The Street is a leading U.S. business television series that profiles innovators and industry disruptors weekly across Bloomberg, Fox Business, and the New York Stock Exchange. With a 17-year track record and a multimedia approach combining sponsored TV, earned media, social content, and billboard visibility, New to The Street offers companies "Opportunities to Consider™." Its official YouTube channel, New to The Street TV, is the fastest-growing financial channel with over 2.47 million subscribers and expanding global viewership. SOURCE: New To The Street
